Covered recipient · General Payments record
NICOLE ANNA KIEFFER
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$890.44
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $872.26 | 52 |
| Education | $5.58 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $365.51 | 23 |
| Amgen Inc. | $240.42 | 14 |
| GlaxoSmithKline, LLC. | $154.19 | 8 |
| Octapharma USA, Inc. | $23.18 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.82 | 1 |
| Radius Health, Inc. | $18.68 | 1 |
| Organon LLC | $15.61 | 2 |
| Genentech USA, Inc. | $14.58 | 1 |
| Lilly USA, LLC | $13.57 | 1 |
| Janssen Biotech, Inc. | $13.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (53)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.43 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069028 | CMS |
| ABBVIE INC. | $18.07 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069030 | CMS |
| ABBVIE INC. | $23.29 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069032 | CMS |
| ABBVIE INC. | $22.72 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069034 | CMS |
| ABBVIE INC. | $4.94 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069036 | CMS |
| ABBVIE INC. | $18.85 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069038 | CMS |
| ABBVIE INC. | $21.16 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069040 | CMS |
| ABBVIE INC. | $3.33 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069042 | CMS |
| ABBVIE INC. | $28.72 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069044 | CMS |
| ABBVIE INC. | $4.98 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069046 | CMS |
| ABBVIE INC. | $20.51 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069048 | CMS |
| ABBVIE INC. | $21.16 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069050 | CMS |
| ABBVIE INC. | $5.44 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069052 | CMS |
| ABBVIE INC. | $4.63 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069054 | CMS |
| ABBVIE INC. | $23.23 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069056 | CMS |
| ABBVIE INC. | $16.61 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069058 | CMS |
| ABBVIE INC. | $20.51 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069060 | CMS |
| ABBVIE INC. | $5.05 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069062 | CMS |
| ABBVIE INC. | $20.20 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069064 | CMS |
| ABBVIE INC. | $17.18 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069066 | CMS |
| ABBVIE INC. | $22.56 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069068 | CMS |
| ABBVIE INC. | $4.90 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069070 | CMS |
| ABBVIE INC. | $17.04 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104069072 | CMS |
| Amgen Inc. | $24.61 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115810824 | CMS |
| Amgen Inc. | $5.58 | 01/29/2024 | Education | Undisputed | 01/23/2026 | 1115810843 | CMS |
| Amgen Inc. | $17.98 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115810832 | CMS |
| Amgen Inc. | $18.98 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115810816 | CMS |
| Amgen Inc. | $26.84 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115810800 | CMS |
| Amgen Inc. | $19.01 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115810808 | CMS |
| Amgen Inc. | $16.63 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117597988 | CMS |
| Amgen Inc. | $17.27 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117597990 | CMS |
| Amgen Inc. | $18.47 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115810792 | CMS |
| Amgen Inc. | $20.94 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115810859 | CMS |
| Amgen Inc. | $1.07 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115810851 | CMS |
| Amgen Inc. | $17.70 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117597992 | CMS |
| Amgen Inc. | $11.67 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115810867 | CMS |
| Amgen Inc. | $23.67 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115810875 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.82 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118112775 | CMS |
| Genentech USA, Inc. | $14.58 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133081544 | CMS |
| GlaxoSmithKline, LLC. | $15.85 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116437437 | CMS |
| GlaxoSmithKline, LLC. | $17.23 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116526574 | CMS |
| GlaxoSmithKline, LLC. | $19.26 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116273160 | CMS |
| GlaxoSmithKline, LLC. | $18.35 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116546331 | CMS |
| GlaxoSmithKline, LLC. | $23.85 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116244730 | CMS |
| GlaxoSmithKline, LLC. | $20.43 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116501469 | CMS |
| GlaxoSmithKline, LLC. | $20.86 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116275257 | CMS |
| GlaxoSmithKline, LLC. | $18.36 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116357122 | CMS |
| Janssen Biotech, Inc. | $13.28 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078829430 | CMS |
| Lilly USA, LLC | $13.57 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135234708 | CMS |
| Octapharma USA, Inc. | $23.18 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142316074 | CMS |
| Organon Llc | $1.06 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136195986 | CMS |
| Organon Llc | $14.55 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136195988 | CMS |
| Radius Health, Inc. | $18.68 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089980256 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.